{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(1)"],"submitter":["Hammond D"],"funding":["NCI NIH HHS"],"journal":["Blood cancer journal"],"pagination":["148"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10514257"],"repository":["biostudies-literature"],"pubmed_title":["Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents."],"pmcid":["PMC10514257"],"funding_grant_id":["P30 CA016672"],"pubmed_authors":["Issa GC","Sasaki K","Ohanian M","Konopleva MY","Montalban-Bravo G","Maiti A","Wang SA","Pierce SR","Short NJ","Garcia-Manero G","Kantarjian HM","Alvarado Y","DiNardo CD","Pemmaraju N","Lachowiez CA","Hammond D","Loghavi S","Daver NG","Jabbour EJ","Takahashi K","Kadia TM","Borthakur G","Ravandi F"],"additional_accession":[]},"is_claimable":false,"name":"Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents.","description":null,"dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Sep","modification":"2024-11-15T18:10:23.833Z","creation":"2024-11-15T18:10:23.833Z"},"accession":"S-EPMC10514257","cross_references":{"pubmed":["37735426"],"doi":["10.1038/s41408-023-00915-6"]}}